SAB Biotherapeutics Operating Margin Growth & History (SABS)

SAB Biotherapeutics's operating margin was −3,244.87% for fiscal 2024.

View full SAB Biotherapeutics company overview

SAB Biotherapeutics annual operating margin history

SAB Biotherapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20242024-12-31−3,244.87%−1544.32 pp
20232023-12-31−1,700.56%−1579.58 pp
20222022-12-31−120.97%−98.97 pp
20212021-12-31−22.00%−59.22 pp
20202020-12-3137.22%—

SAB Biotherapeutics operating margin trends

Between the periods ended 2020-12-31 and 2024-12-31, SAB Biotherapeutics's operating margin decreased from 37.22% to −3,244.87%, a change of −3282.09 percentage points. The latest reported quarter, Q4 2024, shows −8,726.26%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review SAB Biotherapeutics source filings ↗

Community posts

It’s quiet here.

No posts about SABS yet. Start the conversation.

Write the first post